216 related articles for article (PubMed ID: 30832685)
1. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Wehrhan F; Gross C; Creutzburg K; Amann K; Ries J; Kesting M; Geppert CI; Weber M
J Transl Med; 2019 Mar; 17(1):69. PubMed ID: 30832685
[TBL] [Abstract][Full Text] [Related]
2. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
[TBL] [Abstract][Full Text] [Related]
3. Macrophage and osteoclast polarization in bisphosphonate associated necrosis and osteoradionecrosis.
Wehrhan F; Moebius P; Amann K; Ries J; Preidl R; Neukam FW; Weber M
J Craniomaxillofac Surg; 2017 Jun; 45(6):944-953. PubMed ID: 28365078
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the histopathological characteristics of osteomyelitis, medication-related osteonecrosis of the jaw, and osteoradionecrosis.
Shuster A; Reiser V; Trejo L; Ianculovici C; Kleinman S; Kaplan I
Int J Oral Maxillofac Surg; 2019 Jan; 48(1):17-22. PubMed ID: 30054185
[TBL] [Abstract][Full Text] [Related]
5. Medication-related osteonecrosis of the jaw, osteoradionecrosis, and osteomyelitis: A comparative histopathological study.
De Antoni CC; Matsumoto MA; Silva AAD; Curi MM; Santiago Júnior JF; Sassi LM; Cardoso CL
Braz Oral Res; 2018; 32():e23. PubMed ID: 29723337
[TBL] [Abstract][Full Text] [Related]
6. Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease.
Marx RE; Tursun R
Int J Oral Maxillofac Surg; 2012 Mar; 41(3):283-9. PubMed ID: 22244079
[TBL] [Abstract][Full Text] [Related]
7. Osteo-radio-necrosis (ORN) and bisphosphonate-related osteonecrosis of the jaws (BRONJ): the histopathological differences under the clinical similarities.
Mitsimponas KT; Moebius P; Amann K; Stockmann P; Schlegel KA; Neukam FW; Wehrhan F
Int J Clin Exp Pathol; 2014; 7(2):496-508. PubMed ID: 24551270
[TBL] [Abstract][Full Text] [Related]
8. Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases.
Hoefert S; Schmitz I; Weichert F; Gaspar M; Eufinger H
Clin Oral Investig; 2015 Mar; 19(2):497-508. PubMed ID: 24957986
[TBL] [Abstract][Full Text] [Related]
9. Bone Margin Analysis for Osteonecrosis and Osteomyelitis of the Jaws.
Qaisi M; Montague L
Oral Maxillofac Surg Clin North Am; 2017 Aug; 29(3):301-313. PubMed ID: 28709531
[TBL] [Abstract][Full Text] [Related]
10. Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.
Akashi M; Wanifuchi S; Iwata E; Takeda D; Kusumoto J; Furudoi S; Komori T
Oral Maxillofac Surg; 2018 Mar; 22(1):59-63. PubMed ID: 29224060
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study of osteomyelitis and osteonecrosis of the jaws and its etiologic implication of bisphosphonate in Asians.
Hong SO; Lee CY; Jung J; Kim DY; Walter C; Kwon YD
Clin Oral Investig; 2017 Jun; 21(5):1905-1911. PubMed ID: 27771829
[TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaws: a 14-year retrospective survey of hospital admissions.
McGowan K; Ivanovski S; Acton C
Aust Dent J; 2018 Jun; 63(2):202-207. PubMed ID: 29432652
[TBL] [Abstract][Full Text] [Related]
13. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
14. Osteoradionecrosis and medication-related osteonecrosis of the jaw: similarities and differences.
Grisar K; Schol M; Schoenaers J; Dormaar T; Coropciuc R; Vander Poorten V; Politis C
Int J Oral Maxillofac Surg; 2016 Dec; 45(12):1592-1599. PubMed ID: 27427547
[TBL] [Abstract][Full Text] [Related]
15. Quantitation and distribution of metallic elements in sequestra of medication-related osteonecrosis of jaw (MRONJ) using inductively coupled plasma atomic emission spectroscopy and synchrotron radiation X-ray fluorescence analysis.
Komiya R; Wada T; Tsushima F; Sakamoto K; Ikeda T; Yamaguchi A; Harada H; Uo M
J Bone Miner Metab; 2019 Jul; 37(4):676-684. PubMed ID: 30465092
[TBL] [Abstract][Full Text] [Related]
16. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
Inchingolo F; Cantore S; Dipalma G; Georgakopoulos I; Almasri M; Gheno E; Motta A; Marrelli M; Farronato D; Ballini A; Marzullo A
J Biol Regul Homeost Agents; 2017; 31(3):811-816. PubMed ID: 28958140
[TBL] [Abstract][Full Text] [Related]
17. Image findings of bisphosphonate related osteonecrosis of jaws comparing with osteoradionecrosis.
Obinata K; Shirai S; Ito H; Nakamura M; Carrozzo M; Macleod I; Carr A; Yamazaki Y; Tei K
Dentomaxillofac Radiol; 2017 Jul; 46(5):20160281. PubMed ID: 28186845
[TBL] [Abstract][Full Text] [Related]
18. A commentary on "Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral Maxillofac. Surg. 41 (2012) 283-289].
Kalmar JR
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):147-8. PubMed ID: 23107998
[No Abstract] [Full Text] [Related]
19. Parathyroid hormone may be a promising therapy for bisphosphonate-related osteonecrosis of jaw bones.
Li YF; Hu J
Int J Oral Maxillofac Surg; 2013 Jan; 42(1):149-50. PubMed ID: 22763138
[No Abstract] [Full Text] [Related]
20. Histomorphologic characteristics of bisphosphonate-related osteonecrosis of the jaw.
Koerdt S; Dax S; Grimaldi H; Ristow O; Kuebler AC; Reuther T
J Oral Pathol Med; 2014 Jul; 43(6):448-53. PubMed ID: 24456519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
